Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Debra J. Bergstrom
Observed name:
Debra Bergstrom
Institution:
Memorial University of Newfoundland
Observed institutions:
Memorial University of Newfoundland,
University of Alberta,
Newfoundland and Labrador Health Services,
Eastern Health
ORCID:
0000-0002-4073-5453
Observed ORCID:
0000-0002-4073-5453
OpenAlex ID:
A5039365657
Consensus Guidelines on the Diagnosis of Multiple Myeloma and Related Disorders: Recommendations of the Myeloma Canada Research Network Consensus Guideline Consortium
2020
·
Debra J. Bergstrom
, Rami Kotb
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
60
Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database
2023
·
Julie Côté
, Richard LeBlanc
, et al.
·
Blood Cancer Journal
·
33
PDF
Management of Myeloma Manifestations and Complications: The Cornerstone of Supportive Care: Recommendation of the Canadian Myeloma Research Group (formerly Myeloma Canada Research Network) Consensus Guideline Consortium
2021
·
Richard LeBlanc
, Debra J. Bergstrom
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
31
Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis
2023
·
Arleigh McCurdy
, Hira Mian
, et al.
·
Blood Cancer Journal
·
27
PDF
Selinexor in Combination with Bortezomib and Dexamethasone (SdB) Demonstrates Significant Activity in Patients with Refractory Multiple Myeloma (MM) Including Proteasome-Inhibitor Refractory Patients: Results of the Phase I Stomp Trial
2016
·
Nizar J. Bahlis
, Rami Kotb
, et al.
·
Blood
·
16
Selinexor Shows Synergy in Combination with Pomalidomide and Low Dose Dexamethasone in Patients with Relapsed / Refractory Multiple Myeloma
2016
·
Christine Chen
, Rami Kotb
, et al.
·
Blood
·
12
First Line Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma: Recommendations from the Canadian Myeloma Research Group Consensus Guideline Consortium
2023
·
Julie Côté
, Rami Kotb
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
10
PDF
Tandem Autologous Stem Cell Transplantation Does Not Benefit High-Risk Myeloma Patients in the Maintenance Era: Real-World Results from The Canadian Myeloma Research Group Database
2024
·
Christopher P. Venner
, Peter Duggan
, et al.
·
Transplantation and Cellular Therapy
·
9
Real-World Results of Autologous Stem Cell Transplantation in Newly Diagnosed Patients with Multiple Myeloma: A Multi-Institutional Report from the Canadian Myeloma Research Group (CMRG) Database
2022
·
Julie Cote
, Richard Leblanc
, et al.
·
Blood
·
8
Long‐term follow‐up of outcomes including progression‐free survival 2 in patients with transplant‐ineligible multiple myeloma in the real‐world practice: A multi‐institutional report from the Canadian Myeloma Research Group (CMRG) database
2024
·
Rayan Kaedbey
, Donna Reece
, et al.
·
eJHaem
·
7
PDF
First Line Treatment of Newly Diagnosed Transplant Eligible Multiple Myeloma Recommendations From a Canadian Consensus Guideline Consortium
2024
·
Sahar Khan
, Debra J. Bergstrom
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
6
PDF
Heritable thrombophilia test utilization and cost savings following guideline-based restrictions: An interrupted time series analysis
2020
·
Debra Bergstrom
, Shweta Mital
, et al.
·
Thrombosis Research
·
6
Real World Data on Outcomes of Anti-CD38 Antibody Refractory, Including Triple Class Refractory, Patients with Multiple Myeloma: A Multi-Institutional Report from the Canadian Myeloma Research Group (CMRG) Database
2022
·
Alissa Visram
, Alfredo De La Torre
, et al.
·
Blood
·
4
Outcome of carfilzomib/pomalidomide‐based regimens after daratumumab‐based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis
2023
·
Richard LeBlanc
, Hira Mian
, et al.
·
European Journal Of Haematology
·
3
PDF
Treatment Patterns and Outcomes of Multiple Myeloma Patients Undergoing Second-Line Therapy: A Canadian Myeloma Research Group (CMRG) Analysis
2025
·
Arleigh McCurdy
, Engin Gul
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
2
Correction: Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis
2023
·
Arleigh McCurdy
, Hira Mian
, et al.
·
Blood Cancer Journal
·
2
PDF
P-201: Outcomes of transplant-ineligible myeloma patients using bortezomib/lenalidomidecontaining regimens in the real world: a report from the Canadian Myeloma Research Group Database
2022
·
Rayan Kaedbey
, Christopher Venner
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
2
Disease Characteristics and Outcomes of 493 Young Myeloma Patients Treated With Modern Therapies: A Canadian Myeloma Research Group Database Study
2024
·
Mégane Tanguay
, Jean Roy
, et al.
·
Cancer Medicine
·
1
PDF
Second Line Treatment and Outcomes of Patients with Multiple Myeloma: A Real World Multi-Institutional Report from the Canadian Myeloma Research Group (CMRG) Database
2023
·
Arleigh McCurdy
, Engin Gul
, et al.
·
Blood
·
1
PDF
Real-world outcomes of patients with multiple myeloma who reach third-line therapy: a Canadian report
2026
·
Martha L. Louzada
, Donna Reece
, et al.
·
Blood Neoplasia
Real-World Outcomes in Myeloma Patients With t (11;14): A Matched Comparison Using the Canadian Myeloma Research Group National Clinical Database
2025
·
Julia Varghese
, Christopher P Venner
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Real-world experience with first-line regimens in transplant-ineligible patients with multiple myeloma
2025
·
Danyal Ladha
, Donna Reece
, et al.
·
Blood
Real-world outcomes of teclistamab for multiple myeloma in Canada: Multi-institutional report from the Canadian myeloma research group (CMRG) database
2025
·
Guido Lancman
, Donna Reece
, et al.
·
Blood
Salvage Autologous Stem Cell Transplantation Outcomes and The Use of Maintenance in Relapsed Multiple Myeloma: Real world evidence from the Canadian Myeloma Research Group Database
2025
·
Rayan Kaedbey
, Christopher P. Venner
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Disease Characteristics and Outcomes of 504 Young Patients Diagnosed with Multiple Myeloma Treated with Modern Therapies in Canada
2023
·
Mégane Tanguay
, Jean Roy
, et al.
·
Blood
PDF
Show more works
View as search
Works count:
31
Citation count:
240
H-index:
8
I10-index:
7
Year
Topic
Type